Charles H. Sherwood
2018
In 2018, Charles H. Sherwood earned a total compensation of $5M as Former Chief Executive Officer at Anika Therapeutics, a 18% increase compared to previous year.
Compensation breakdown
| Salary | $147,877 |
|---|---|
| Stock Awards | $3,509,937 |
| Other | $1,339,364 |
| Total | $4,997,178 |
Sherwood received $3.5M in stock awards, accounting for 70% of the total pay in 2018.
Sherwood also received $147.9K in salary and $1.3M in other compensation.
Rankings
In 2018, Charles H. Sherwood's compensation ranked 2,013th out of 14,244 executives tracked by ExecPay. In other words, Sherwood earned more than 85.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,013 out of 14,244 | 86th |
Division Manufacturing | 726 out of 5,759 | 87th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 86 out of 849 | 90th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 39 out of 547 | 93rd |
Industry Surgical and Medical Instruments and Apparatus | 21 out of 348 | 94th |
Source: SEC filing on April 25, 2019.
Sherwood's colleagues
We found five more compensation records of executives who worked with Charles H. Sherwood at Anika Therapeutics in 2018.
2018
Joseph Darling
Anika Therapeutics
Chief Executive Officer
2018
Sylvia Cheung
Anika Therapeutics
Chief Financial Officer
2018
Edward Ahn
Anika Therapeutics
Chief Technology and Strategy Officer
2018
Richard Hague
Anika Therapeutics
Chief Commercial Officer
2018
Thomas Finnerty
Anika Therapeutics